CERTIFICATE

IMPACT FACTOR 2021

Subject Area

  • Life Sciences / Biology
  • Architecture / Building Management
  • Asian Studies
  • Business & Management
  • Chemistry
  • Computer Science
  • Economics & Finance
  • Engineering / Acoustics
  • Environmental Science
  • Agricultural Sciences
  • Pharmaceutical Sciences
  • General Sciences
  • Materials Science
  • Mathematics
  • Medicine
  • Nanotechnology & Nanoscience
  • Nonlinear Science
  • Chaos & Dynamical Systems
  • Physics
  • Social Sciences & Humanities

Why Us? >>

  • Open Access
  • Peer Reviewed
  • Rapid Publication
  • Life time hosting
  • Free promotion service
  • Free indexing service
  • More citations
  • Search engine friendly

Significance of third trimester hba1c as a predictor of adverse obstetric outcome in diabetic mothers- a prospective observational study

Author: 
Charlene Rodrigues, Usha Krishnakumar and Josephine Wilson
Subject Area: 
Health Sciences
Abstract: 

Background: Diabetes is emerging as a new epidemic in today’s era with the increase in obesity and sedentary lifestyles, affecting a large proportion of the female population extending to reproductive age group. It is well known to have short and long term consequences for the fetus and mother. Thus, proper control of diabetes in pregnancy is essential to ensure better obstetric outcomes. Objective: The present study was undertaken to determine the significance of HbA1c levels in third trimester in predicting adverse maternal and fetal outcomes. Methods: It was a Prospective observational study of 100 pregnant women with diabetes who attended the antenatal clinic and delivered at St. Isabel’s hospital, Chennai from May 2017 to Oct. 2017. Pre-gestational diabetes was diagnosed according to ADA criteria and testing for GDM was done with 75g Oral Glucose Tolerance Test (OGTT) according to IADPSG criteria at the first visit and at 24 -28 weeks. Patients with diabetes were managed according to hyperglycemia control. Hba1c value in late third trimester or at time of delivery was noted and a value of < 6% was considered normal. Obstetrical and perinatal outcomes were noted and the data was compared using Chi-square test. Odds ratio and 95% confidence interval were used to compare association of HbA1c with various maternal and neonatal complications. Regression analysis was used to estimate the relationship among various categorical variables. Results: Fetomaternal outcomes were compared among patients with HBA1c ≥6% and <6%. Adverse maternal outcomes when HbA1c was ≥6% included hypertension (42% vs. 6%, p<0.001, OR=11.7) and preterm labour (35% vs. 14%, p=0.01, OR=3.24). Spontaneous onset of labour (19% vs. 42%) when HbA1c was ≥6% with greater percentage of vaginal deliveries when HbA1c <6% (80% vs 20%). Neonatal outcome analysis revealed higher birth weight (51% vs. 39%, p=0.013) and greater incidence of LGA (45% vs. 3%, p<0.001, OR=27.5) with HbA1c ≥6%. Adverse neonatal metabolic complications included hypoglycemia (39% vs. 7%, p=0.001, OR=8.08), hyperbilirubinemia (58% vs. 29%, p=0.006, OR=3.39) and hypocalcemia (16% vs. 3%, p=0.016, OR=6.44). Regression analysis of various maternal and neonatal complications showed highest relation of third trimester HbA1c with maternal hypertension (p=0.002) followed by LGA (p=0.01). Conclusion: HbA1c is a sensitive tool for prediction of foetomaternal complication in patients with diabetes and should be advised to ensure optimum outcomes when self monitoring of blood glucose is not feasible.

PDF file: 

CALL FOR PAPERS

 

ONLINE PAYPAL PAYMENT

IJMCE RECOMMENDATION

Advantages of IJCR

  • Rapid Publishing
  • Professional publishing practices
  • Indexing in leading database
  • High level of citation
  • High Qualitiy reader base
  • High level author suport

Plagiarism Detection

IJCR is following an instant policy on rejection those received papers with plagiarism rate of more than 20%. So, All of authors and contributors must check their papers before submission to making assurance of following our anti-plagiarism policies.

 

EDITORIAL BOARD

CHUDE NKIRU PATRICIA
Nigeria
Dr. Swamy KRM
India
Dr. Abdul Hannan A.M.S
Saudi Arabia.
Luai Farhan Zghair
Iraq
Hasan Ali Abed Al-Zu’bi
Jordanian
Fredrick OJIJA
Tanzanian
Firuza M. Tursunkhodjaeva
Uzbekistan
Faraz Ahmed Farooqi
Saudi Arabia
Eric Randy Reyes Politud
Philippines
Elsadig Gasoom FadelAlla Elbashir
Sudan
Eapen, Asha Sarah
United State
Dr.Arun Kumar A
India
Dr. Zafar Iqbal
Pakistan
Dr. SHAHERA S.PATEL
India
Dr. Ruchika Khanna
India
Dr. Recep TAS
Turkey
Dr. Rasha Ali Eldeeb
Egypt
Dr. Pralhad Kanhaiyalal Rahangdale
India
DR. PATRICK D. CERNA
Philippines
Dr. Nicolas Padilla- Raygoza
Mexico
Dr. Mustafa Y. G. Younis
Libiya
Dr. Muhammad shoaib Ahmedani
Saudi Arabia
DR. MUHAMMAD ISMAIL MOHMAND
United State
DR. MAHESH SHIVAJI CHAVAN
India
DR. M. ARUNA
India
Dr. Lim Gee Nee
Malaysia
Dr. Jatinder Pal Singh Chawla
India
DR. IRAM BOKHARI
Pakistan
Dr. FARHAT NAZ RAHMAN
Pakistan
Dr. Devendra kumar Gupta
India
Dr. ASHWANI KUMAR DUBEY
India
Dr. Ali Seidi
Iran
Dr. Achmad Choerudin
Indonesia
Dr Ashok Kumar Verma
India
Thi Mong Diep NGUYEN
France
Dr. Muhammad Akram
Pakistan
Dr. Imran Azad
Oman
Dr. Meenakshi Malik
India
Aseel Hadi Hamzah
Iraq
Anam Bhatti
Malaysia
Md. Amir Hossain
Bangladesh
Ahmet İPEKÇİ
Turkey
Mirzadi Gohari
Iran